Condition: Parkinson's Disease · Sponsor: University Hospital, Lille
PARKINSUN is a new communication aid tool, expected to favor global patient centered care for PD patients during consultation with GPs and neurologists. Two groups of patients will be randomized to use or not PARKINSUN when they consult their physicians every 3 months during 7 months.
This description comes directly from the study's public registry record.
David Devos, MD,PhD · 03 20 44 54 49 · david.devos@chru-lille.fr
Always discuss trial participation with your own doctor first.
| Hopital Roger Salengro, CHU Lille | Lille, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04179695